Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongqing Yan

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 31, 2021
Surgical outcomes of two different reconstruction routes for esophagectomy in esophageal cancer patients: a meta-analysisDongqing Yan, Hongjie Zheng, Peijie Wang, et al.
Leukemia|May 12, 2018
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashionWilliam L Heaton, Anna V Senina, Anthony D Pomicter, et al.
Leukemia|January 26, 2020
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cellsHein Than, Anthony D Pomicter, Dongqing Yan, et al.
Leukemia|May 16, 2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanismsAmi B Patel, Anthony D Pomicter, Dongqing Yan, et al.
Haematologica|July 10, 2025
The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemiaHelong Gary Zhao, Nataly Cruz-Rodriguez, Kent C Johnson, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Blood|November 15, 2021
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosisHelong Zhao, Anthony D Pomicter, Anna M Eiring, et al.
Clinical and Translational Medicine|December 19, 2022
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolismMayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 31, 2021
Surgical outcomes of two different reconstruction routes for esophagectomy in esophageal cancer patients: a meta-analysisDongqing Yan, Hongjie Zheng, Peijie Wang, et al.
Leukemia|May 12, 2018
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashionWilliam L Heaton, Anna V Senina, Anthony D Pomicter, et al.
Leukemia|January 26, 2020
Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cellsHein Than, Anthony D Pomicter, Dongqing Yan, et al.
Leukemia|May 16, 2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanismsAmi B Patel, Anthony D Pomicter, Dongqing Yan, et al.
Haematologica|July 10, 2025
The small GTPase ARF6 regulates sphingolipid homeostasis and supports proliferation in acute myeloid leukemiaHelong Gary Zhao, Nataly Cruz-Rodriguez, Kent C Johnson, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Cancer Cell|September 24, 2019
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 MutantsChristopher A Eide, Matthew S Zabriskie, Samantha L Savage Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Blood|November 15, 2021
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosisHelong Zhao, Anthony D Pomicter, Anna M Eiring, et al.
Clinical and Translational Medicine|December 19, 2022
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolismMayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, et al.
Pageof 5